Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 2 of the 13 calendar months from Oct 2025 to Oct 2026: Feb 2026 and Mar 2026.
- Largest single sale: $1.5M (5,700 shares) of Krystal Biotech, Inc. on Feb 9, 2026. Filing
- Last sale before this period: Feb 27, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Krystal Biotech, Inc. (KRYS) | Chief Accounting Officer | Feb 25, 2020 | Mar 3, 2026 |
Recent filings
The last 3 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Mar 2, 2026, Krystal Biotech, Inc.: sold 750 shares for $201K, under a disclosed plan. 1 filing: 1
- Feb 27, 2026, Krystal Biotech, Inc.: 8,050 shares vested; 3,502 shares withheld by the company for taxes. 1 filing: 1
- Feb 9, 2026, Krystal Biotech, Inc.: sold 12,500 shares for $3.4M, under a disclosed plan; 12,500 shares acquired by exercising options; 750 shares given away. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.